Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus

Completed · Not applicable · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

This is a research study designed to look at how pomegranate juice (or a placebo juice) affects the body through the measurement of specific biomarkers, which are indicators of health.

Key facts

Study ID

NCT00668954

Run by

University of Colorado, Denver

People needed

26

Starts

2008-04-01

Expected to finish

2010-11-01

Last updated by the study team

2015-07-31

Who can join

Age: 35 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to speak and read English
• Have a diagnosis of Type II Diabetes Mellitus and currently being treated with oral medication
• Have an HbA1C level ≤9.0% at Screening
• Have an hsCRP level ≥ 1.0 at Screening
• 35 - 70 years old (inclusive)
• Non-smokers
• Willing to maintain his/her normal activity and eating patterns for the duration of the study
• Willing to maintain his/her normal diet for the duration of the study but avoid anti-oxidant rich foods and pomegranate juice (other than what is dispensed to them)

You may not qualify if…

• Allergy to pomegranates
• Currently using insulin
• Currently taking steroidal drugs
• HIV positive or AIDS
• Chronic infectious disease
• Recent (within 2 weeks of screening) cold/flu, inflammatory illness, or flare-up of gout
• Cancer treated within the past two years
• Participation in a therapeutic research study within 30 days of baseline
• Women who are pregnant, lactating, or planning to become pregnant during the study period

Where it is running

• University of Colorado Denver Center for Human Nutrition — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.